- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Taizhou Cancer Hospital
Total 9996 results
-
Barretos Cancer HospitalRecruiting
-
Henan Cancer HospitalRecruitingSquamous Cell Carcinoma of the SkinChina
-
Fujian Cancer HospitalNot yet recruiting
-
Hubei Cancer HospitalRecruitingSelected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma (iCSDeR)Surgery | Head and Neck Squamous Cell Carcinoma | Radiotherapy | ImmunotherapyChina
-
Hunan Cancer HospitalRecruiting
-
Henan Cancer HospitalRecruitingNon-small Cell Lung CancerChina
-
Henan Cancer HospitalRecruiting
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Fujian Cancer HospitalRecruitingColorectal Cancer | ImmunotherapyChina
-
Henan Cancer HospitalRecruiting
-
Fujian Cancer HospitalRecruitingMetastatic Colorectal CancerChina
-
Zhejiang Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalRecruitingNasopharyngeal CarcinomaChina
-
Zhejiang Cancer HospitalNot yet recruitingUterine Cervical Neoplasms | Oncolytic Virotherapy | CamrelizumabChina
-
Henan Cancer HospitalRecruitingCentral Nervous System LymphomaChina
-
Henan Cancer HospitalNot yet recruiting
-
Zhejiang Cancer HospitalRecruitingColorectal Cancer Metastatic | Microsatellite Stable | Mismatch Repair-proficientChina
-
Hubei Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalRecruiting
-
Fujian Cancer HospitalNot yet recruitingColorectal Cancer Stage II | Colorectal Cancer Stage III
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Henan Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalRecruiting
-
Hubei Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalRecruitingCervical CancerChina
-
Zhejiang Cancer HospitalNot yet recruitingSmall Cell Lung Cancer Extensive Stage
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Zhejiang Cancer HospitalNot yet recruitingChemotherapy Effect | Gray Zone Lymphoma | Relapse/Recurrence
-
Henan Cancer HospitalRecruitingNSCLC | Brain Metastases | Leptomeningeal MetastasisChina
-
Henan Cancer HospitalRecruitingAdvanced Gastric AdenocarcinomaChina
-
Henan Cancer HospitalRecruitingDiffuse Large B Cell Lymphoma | CD79A Gene Mutation | CD79B Gene MutationChina
-
Zhejiang Cancer HospitalNot yet recruiting
-
Zhejiang Cancer HospitalNot yet recruitingLocally Advanced Rectal CancerChina
-
Henan Cancer HospitalRecruitingAlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung CancerSCLC, Extensive StageChina
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
Henan Cancer HospitalRecruitingGastric and Esophagogastric Junction AdenocarcinomaChina
-
Henan Cancer HospitalNot yet recruitingNon-small Cell Lung Cancer Metastatic
-
Zhejiang Cancer HospitalNot yet recruiting
-
Zhejiang Cancer HospitalNot yet recruitingUnresectable Stage III NSCLC
-
Fujian Cancer HospitalNot yet recruitingGastric Cancer
-
Henan Cancer HospitalRecruitingEsophageal Squamous Cell CarcinomaChina
-
Henan Cancer HospitalRecruitingClassical Hodgkin LymphomaChina
-
Henan Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalRecruitingGastric AdenocarcinomaChina
-
Barretos Cancer HospitalRecruitingLocally Advanced Malignant NeoplasmBrazil
-
Fujian Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalRecruitingSurgery | Esophageal Carcinoma | Neoadjuvant ChemoradiotherapyChina
-
Zhejiang Cancer HospitalRecruitingNeoplasm Metastasis | Nasopharyngeal CancerChina